No longer a life-threatening disease, sickle cell disease (SCD) has become a chronic disease with life-threatening events that requires coordinated care by a multidisciplinary care team. Join Michael R. DeBaun, MD, MPH, and Collin Montgomery, APRN, as they discuss the acute and chronic complications experienced by individuals with SCD and the barriers they often encounter. The faculty offer real-world strategies for overcoming these barriers to improve the quality of life and other health outcomes of patients with SCD. Learn about 4 medications approved for treating acute and chronic complications of SCD and how to optimize their use. Case studies are utilized to share the faculty’s experience and to facilitate integration into clinical practice.
1.25 AANP Contact Hours
1.25 AMA PRA Category 1 CreditsTM
This activity was developed for pediatric and adult hematologists, hematology nurse practitioners, emergency physicians, primary care physicians, pediatricians and other clinicians involved in the management of patients with sickle cell disease.
This activity is supported by an independent educational grant from Novartis. This Program is supported by a grant from Global Blood Therapeutics, Inc. This activity is supported in part by a grant from bluebird, bio, Inc.
Michael R. DeBaun, MD, MPH
Professor of Pediatrics and Medicine
Vice Chair for Clinical and Translational Research
J.C. Peterson Chair in Pediatric Pulmonology
Director, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease
Vanderbilt Children’s Hospital
Collin Montgomery, APRN
APRN Coordinator, UAMS Adult Sickle Cell Program
University of Arkansas for Medical Sciences
Division of Hematology and Oncology
Department of Internal Medicine
UAMS Medical Center
Little Rock, Arkansas